 | Up a level |
Röhrig, F; Vorlová, S; Hoffmann, H; Wartenberg, Martin; Escorcia, F E; Keller, S; Tenspolde, M; Weigand, I; Gätzner, S; Manova, K; Penack, O; Scheinberg, D A; Rosenwald, A; Ergün, S; Granot, Z; Henke, E (2016). VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors. Oncogene, 36(1), pp. 1-12. Nature Publishing Group 10.1038/onc.2016.182
